James O’Hara

1.8k total citations
86 papers, 1.1k citations indexed

About

James O’Hara is a scholar working on Surgery, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, James O’Hara has authored 86 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Surgery, 38 papers in Otorhinolaryngology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in James O’Hara's work include Head and Neck Cancer Studies (33 papers), Tracheal and airway disorders (13 papers) and Head and Neck Surgical Oncology (13 papers). James O’Hara is often cited by papers focused on Head and Neck Cancer Studies (33 papers), Tracheal and airway disorders (13 papers) and Head and Neck Surgical Oncology (13 papers). James O’Hara collaborates with scholars based in United Kingdom, United States and Canada. James O’Hara's co-authors include Karey L. O’Hara, Nick S. Jones, Vinidh Paleri, J. A. Wilson, Max Robinson, Jarrod J. Homer, D. Meikle, Joanne Patterson, Paul Carding and David W. Hamilton and has published in prestigious journals such as Cancer Research, BMJ and Anesthesiology.

In The Last Decade

James O’Hara

78 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James O’Hara United Kingdom 20 468 406 340 216 199 86 1.1k
Jason Powell United Kingdom 15 280 0.6× 91 0.2× 400 1.2× 175 0.8× 41 0.2× 51 888
Mustafa Çelik Türkiye 16 280 0.6× 107 0.3× 82 0.2× 167 0.8× 60 0.3× 113 888
Michael K. Gupta Canada 16 395 0.8× 210 0.5× 136 0.4× 231 1.1× 132 0.7× 52 859
Jordan T. Glicksman United States 15 264 0.6× 214 0.5× 89 0.3× 98 0.5× 40 0.2× 41 540
Clifton T. Furukawa United States 22 164 0.4× 314 0.8× 566 1.7× 650 3.0× 51 0.3× 54 1.4k
Douglas M. Hildrew United States 8 148 0.3× 67 0.2× 253 0.7× 462 2.1× 28 0.1× 21 773
Chi‐Ming Tai Taiwan 26 1.2k 2.6× 30 0.1× 385 1.1× 319 1.5× 85 0.4× 98 1.9k
Diahn‐Warng Perng Taiwan 21 160 0.3× 24 0.1× 805 2.4× 822 3.8× 83 0.4× 68 1.6k
Emily Brennan United States 14 204 0.4× 164 0.4× 147 0.4× 45 0.2× 167 0.8× 58 730
John G. Park United States 14 276 0.6× 33 0.1× 202 0.6× 410 1.9× 57 0.3× 38 905

Countries citing papers authored by James O’Hara

Since Specialization
Citations

This map shows the geographic impact of James O’Hara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James O’Hara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James O’Hara more than expected).

Fields of papers citing papers by James O’Hara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James O’Hara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James O’Hara. The network helps show where James O’Hara may publish in the future.

Co-authorship network of co-authors of James O’Hara

This figure shows the co-authorship network connecting the top 25 collaborators of James O’Hara. A scholar is included among the top collaborators of James O’Hara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James O’Hara. James O’Hara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Hara, James, et al.. (2025). Clinical Profile and Referral Pathways in Late Radiation‐Associated Dysphagia (Late‐RAD): A Consecutive Case Series. Clinical Otolaryngology. 50(4). 785–789. 1 indexed citations
2.
Haighton, Catherine, et al.. (2025). Assessment and management of late radiation‐associated dysphagia after treatment for head and neck cancer: A scoping review and survey of UK speech and language therapists. International Journal of Language & Communication Disorders. 60(1). e13154–e13154. 3 indexed citations
3.
4.
Rajgor, Amarkumar Dhirajlal, Colin S. Gillespie, Chang Woo Lee, et al.. (2024). Outcomes of the modern management approach for locally advanced (T3–T4) laryngeal cancer: a retrospective cohort study. The Journal of Laryngology & Otology. 138(12). 1154–1160.
5.
O’Hara, James, et al.. (2024). Social Interest Data as a Proxy for Off-Label Performance-Enhancing Drug Use: Implications and Clinical Considerations. Cureus. 16(1). e52011–e52011. 2 indexed citations
6.
Sharp, Linda, et al.. (2024). People, places, systems and society:A qualitative exploration of socio-cultural factors in head and neck cancer survivorship. European Journal of Oncology Nursing. 72. 102682–102682.
7.
Parker, Sean, John A. Smith, Surinder S. Birring, et al.. (2023). British Thoracic Society Clinical Statement on chronic cough in adults. Thorax. 78(Suppl 6). s3–s19. 29 indexed citations
8.
Bissett, Susan M., M Carrozzo, Michael Nugent, et al.. (2023). Qualitative interview study exploring the early identification and referral of patients with suspected head and neck cancer by community pharmacists in England. BMJ Open. 13(3). e068607–e068607. 5 indexed citations
9.
Hamilton, David W., et al.. (2023). Outcomes of an Advanced Speech and Language Therapist-Led Low-Risk 2-Week Wait Clinic for Suspected Head and Neck Cancer: A UK-Based Pilot Study. Journal of Voice. 39(4). 1138.e1–1138.e7. 3 indexed citations
10.
Goodfellow, Michael, et al.. (2023). Novel method to plan and design services. Using software to optimise the head and neck cancer patient’s commute to hospital. British Journal of Oral and Maxillofacial Surgery. 62(2). 150–156.
11.
Warner, Laura, James O’Hara, Daniel J. Lin, et al.. (2022). Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes. Oral Oncology. 130. 105909–105909. 19 indexed citations
12.
O’Hara, James, Deborah Stocken, Gillian Watson, et al.. (2021). Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial. BMJ. 372. m4903–m4903. 36 indexed citations
13.
14.
Fisher, Holly, Vinidh Paleri, Max Robinson, et al.. (2020). How applicable is the TNM 8 staging for human papillomavirus (HPV) related oropharyngeal squamous cell carcinoma (OPSCC) to a UK population of 106 patients?. European Archives of Oto-Rhino-Laryngology. 278(3). 755–761.
15.
Iqbal, Muhammad Shahid, David Wilkinson, Paolo Bossi, et al.. (2019). Cetuximab in the management of nasopharyngeal carcinoma – a narrative review. The Journal of Laryngology & Otology. 133(10). 843–855. 2 indexed citations
16.
Siddiq, Somiah, David Cartlidge, S. Stephen, et al.. (2018). Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with high risk human papillomavirus related squamous cell cancer. European Archives of Oto-Rhino-Laryngology. 275(7). 1853–1860. 5 indexed citations
17.
Watson, Gillian, James O’Hara, Paul Carding, et al.. (2016). TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial. Trials. 17(1). 175–175. 6 indexed citations
18.
Mehanna, Hisham, Mark D. Evans, Matthew Beasley, et al.. (2016). Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines. The Journal of Laryngology & Otology. 130(S2). S90–S96. 81 indexed citations
19.
Haighton, Catherine, James O’Hara, Nikki Rousseau, et al.. (2015). The NAtional randomised controlled Trial of Tonsillectomy IN Adults (NATTINA): a clinical and cost-effectiveness study: study protocol for a randomised control trial. Trials. 16(1). 263–263. 15 indexed citations
20.
O’Hara, James, et al.. (2006). The significance of MRI findings for non‐rhinological disease*. Clinical Otolaryngology. 31(4). 292–296. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason Powell Breakdown of academic impact, for papers by Mustafa Çelik Breakdown of academic impact, for papers by Michael K. Gupta Breakdown of academic impact, for papers by Jordan T. Glicksman Breakdown of academic impact, for papers by Clifton T. Furukawa Breakdown of academic impact, for papers by Douglas M. Hildrew Breakdown of academic impact, for papers by Chi‐Ming Tai Breakdown of academic impact, for papers by Diahn‐Warng Perng Breakdown of academic impact, for papers by Emily Brennan Breakdown of academic impact, for papers by John G. Park
Rankless by CCL
2026